13F HOLDINGS REPORT
Affinity Asset Advisors, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001999371-23-000200
Total Value
$355.5M
Positions
81
Other Managers
0
Confidential Omitted
No
Holdings (81)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 1,045,110 | $22.3M | 6.26% |
| 2 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 2,000,000 | $20.4M | 5.74% |
| 3 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,129,376 | $16.8M | 4.74% |
| 4 | BRIDGEBIO PHARMA INC | BBIO | 17,000,000 | $16.4M | 4.62% |
| 5 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 685,061 | $15.0M | 4.21% |
| 6 | ARCELLX INC | ACLX | 400,000 | $14.4M | 4.04% |
| 7 | CRINETICS PHARMACEUTICALS IN | CRNX | 450,000 | $13.4M | 3.76% |
| 8 | MADRIGAL PHARMACEUTICALS INC | MDGL | 85,000 | $12.4M | 3.49% |
| 9 | ESTABLISHMENT LABS HLDGS INC | ESTA | 239,108 | $11.7M | 3.30% |
| 10 | IMMUNOVANT INC | IMVT | 300,000 | $11.5M | 3.24% |
| 11 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,100,000 | $11.2M | 3.16% |
| 12 | XENON PHARMACEUTICALS INC | XENE | 300,438 | $10.3M | 2.89% |
| 13 | KURA ONCOLOGY INC | KURA | 856,535 | $7.8M | 2.20% |
| 14 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,000,300 | $7.5M | 2.10% |
| 15 | ARK ETF TR | 00214Q302 | 250,000 | $7.0M | 1.96% |
| 16 | ESTABLISHMENT LABS HLDGS INC | ESTA | 140,000 | $6.9M | 1.93% |
| 17 | CYTOKINETICS INC | CYTK | 230,366 | $6.8M | 1.91% |
| 18 | KRYSTAL BIOTECH INC | KRYS | 57,500 | $6.7M | 1.88% |
| 19 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,018,091 | $6.6M | 1.85% |
| 20 | MORPHIC HLDG INC | 61775R105 | 270,000 | $6.2M | 1.74% |
| 21 | VERONA PHARMA PLC | 925050106 | 368,329 | $6.0M | 1.69% |
| 22 | INOZYME PHARMA INC | 45790W108 | 1,379,852 | $5.8M | 1.63% |
| 23 | ALKERMES PLC | ALKS | 200,000 | $5.6M | 1.58% |
| 24 | APELLIS PHARMACEUTICALS INC | APLS | 130,000 | $4.9M | 1.39% |
| 25 | IMMUNOVANT INC | IMVT | 128,100 | $4.9M | 1.38% |
| 26 | AUTOLUS THERAPEUTICS PLC | AUTL | 1,992,466 | $4.6M | 1.31% |
| 27 | SAVARA INC | SVRA | 1,150,000 | $4.3M | 1.22% |
| 28 | ASCENDIS PHARMA A/S | ASND | 46,400 | $4.3M | 1.22% |
| 29 | CELLDEX THERAPEUTICS INC NEW | CLDX | 150,000 | $4.1M | 1.16% |
| 30 | ASTRAZENECA PLC | AZN | 60,000 | $4.1M | 1.14% |
| 31 | TANGO THERAPEUTICS INC | TNGX | 350,000 | $3.9M | 1.11% |
| 32 | PROTHENA CORP PLC | PRTA | 79,214 | $3.8M | 1.08% |
| 33 | VIKING THERAPEUTICS INC | VKTX | 332,600 | $3.7M | 1.04% |
| 34 | MERSANA THERAPEUTICS INC | 59045L106 | 2,850,000 | $3.6M | 1.02% |
| 35 | VIKING THERAPEUTICS INC | VKTX | 300,000 | $3.3M | 0.93% |
| 36 | AEGLEA BIOTHERAPEUTICS INC | SYRE | 242,297 | $3.0M | 0.83% |
| 37 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 200,000 | $3.0M | 0.83% |
| 38 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 50,000 | $2.9M | 0.80% |
| 39 | ALKERMES PLC | ALKS | 100,000 | $2.8M | 0.79% |
| 40 | KALVISTA PHARMACEUTICALS INC | KALV | 278,292 | $2.7M | 0.75% |
| 41 | MIRATI THERAPEUTICS INC | 60468T105 | 60,426 | $2.6M | 0.74% |
| 42 | IMMATICS N.V | IMTX | 200,000 | $2.3M | 0.65% |
| 43 | NUVALENT INC | NUVL | 50,000 | $2.3M | 0.65% |
| 44 | SEAGEN INC | SE | 10,000 | $2.1M | 0.60% |
| 45 | LANTHEUS HLDGS INC | LNTH | 30,000 | $2.1M | 0.59% |
| 46 | NURIX THERAPEUTICS INC | NRIX | 250,000 | $2.0M | 0.55% |
| 47 | ACLARIS THERAPEUTICS INC | ACRS | 260,000 | $1.8M | 0.50% |
| 48 | ROIVANT SCIENCES LTD | ROIV | 150,000 | $1.8M | 0.49% |
| 49 | TERNS PHARMACEUTICALS INC | TERN | 325,000 | $1.6M | 0.46% |
| 50 | APELLIS PHARMACEUTICALS INC | APLS | 40,000 | $1.5M | 0.43% |
| 51 | VAXCYTE INC | PCVX | 25,000 | $1.3M | 0.36% |
| 52 | INSPIRE MED SYS INC | 457730109 | 6,293 | $1.2M | 0.35% |
| 53 | EYEPOINT PHARMACEUTICALS INC | EYPT | 155,000 | $1.2M | 0.35% |
| 54 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 125,000 | $1.2M | 0.33% |
| 55 | MORPHIC HLDG INC | 61775R105 | 50,000 | $1.1M | 0.32% |
| 56 | TALARIS THERAPEUTICS INC | 87410C104 | 400,000 | $1.1M | 0.32% |
| 57 | THESEUS PHARMACEUTICALS INC | 88369M101 | 400,726 | $1.1M | 0.30% |
| 58 | MILESTONE PHARMACEUTICALS IN | MIST | 335,068 | $1.0M | 0.29% |
| 59 | LIANBIO | LIANY | 672,357 | $1.0M | 0.28% |
| 60 | ADC THERAPEUTICS SA | ADCT | 1,100,000 | $986,700 | 0.28% |
| 61 | INFLARX NV | IFRX | 325,097 | $968,789 | 0.27% |
| 62 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 41,581 | $961,353 | 0.27% |
| 63 | MIRUM PHARMACEUTICALS INC | MIRM | 30,000 | $948,000 | 0.27% |
| 64 | TRAVERE THERAPEUTICS INC | TVTX | 100,000 | $894,000 | 0.25% |
| 65 | INSULET CORP | PODD | 5,000 | $797,450 | 0.22% |
| 66 | BRIDGEBIO PHARMA INC | BBIO | 30,000 | $791,100 | 0.22% |
| 67 | BIOHAVEN LTD | BHVN | 30,156 | $784,358 | 0.22% |
| 68 | AVROBIO INC | 05455M100 | 500,000 | $770,000 | 0.22% |
| 69 | IMMATICS N.V | IMTX | 187,204 | $662,702 | 0.19% |
| 70 | 89BIO INC | 282559103 | 37,300 | $575,912 | 0.16% |
| 71 | PUMA BIOTECHNOLOGY INC | PBYI | 202,349 | $532,178 | 0.15% |
| 72 | PROMIS NEUROSCIENCES INC | PMN | 265,958 | $526,677 | 0.15% |
| 73 | CONTEXT THERAPEUTICS INC | CNTX | 328,817 | $496,514 | 0.14% |
| 74 | MESOBLAST LTD | MEOBF | 400,000 | $492,000 | 0.14% |
| 75 | NUVATION BIO INC | NUVB | 250,000 | $335,000 | 0.09% |
| 76 | BIOATLA INC | BCAB | 180,000 | $306,000 | 0.09% |
| 77 | ALDEYRA THERAPEUTICS INC | ALDX | 44,348 | $296,245 | 0.08% |
| 78 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 137,000 | $260,300 | 0.07% |
| 79 | NLS PHARMACEUTICS LTD | H57830103 | 200,455 | $140,319 | 0.04% |
| 80 | ARAVIVE INC | 03890D108 | 346,511 | $45,739 | 0.01% |
| 81 | ROCKET PHARMACEUTICALS INC | RCKTW | 75,000 | $7,500 | 0.00% |